|
|
R-flurbiprofen
An orally active synthetic enantiomer of flurbiprofen. R-flurbiprofen activates c-Jun N terminal kinase, increases AP-1 binding to DNA, and downregulates cyclin D1 expression, resulting in arrest of tumor cells in the G1 phase of the cell cycle and apoptosis. This agent also affects the expression of nuclear factor kappa B, a rapid response transcription factor that stimulates the immune response to tumor cells. R-flurbiprofen does not inhibit the enzyme cyclo-oxygenase. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Flurizan | | | | Code names: | | E-7869
MPC-7869
| | | | Chemical structure name: | | (R)-2-Fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid | | |
|
|
